Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome - PubMed (original) (raw)

. 2010 Dec;25(4):397-405.

doi: 10.1007/s11011-010-9221-y. Epub 2010 Nov 10.

Affiliations

• PMID: 21063759
• DOI: 10.1007/s11011-010-9221-y

Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome

Andreana P Haley et al. Metab Brain Dis. 2010 Dec.

Abstract

Metabolic syndrome (MetS) is a cluster of risk factors associated with significant cardiovascular morbidity and mortality and diminished cognitive function. Given that the cerebral mechanisms mediating the relationship between peripheral metabolic dysfunction and cognitive impairment are unknown, we set out to examine the relationship between diagnosis of metabolic syndrome and cerebral metabolism. Thirteen participants with MetS (aged 48 ± 6 years) and 25 healthy adults (aged 51 ± 6 years) underwent neuropsychological assessment, health screen and proton magnetic resonance spectroscopy ((1)H MRS) examining N-acetyl-aspartate (NAA), myo-inositol (mI), creatine (Cr), choline (Cho), and glutamate (Glu) concentrations in occipitoparietal grey matter. Cerebral metabolite ratios (NAA/Cr, Cho/Cr, mI/Cr, and Glu/Cr) of participants with MetS, defined by the International Diabetes Federation criteria, were compared with controls matched for age, education, cognition, and emotional function. There were no significant differences in global cognitive function, memory, language, and psychomotor performance between the groups. Diagnosis of MetS was associated with significantly higher mI/Cr (F(1,36) = 5.02, p = 0.031) and Glu/Cr ratio (F(1,36) = 4.81, p = 0.035). Even in cognitively normal adults, MetS is related to cerebral metabolic disturbances, a possible indication of early brain vulnerability. Longitudinal studies that begin in mid-life can help validate the use of (1)H MRS markers as indicators of long-term cognitive outcomes.

PubMed Disclaimer

Similar articles

• Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations.
  Gonzales MM, Tarumi T, Eagan DE, Tanaka H, Vaghasia M, Haley AP. Gonzales MM, et al. Psychosom Med. 2012 Sep;74(7):691-8. doi: 10.1097/PSY.0b013e31825ff1de. Epub 2012 Jul 20. Psychosom Med. 2012. PMID: 22822230 Free PMC article.
• Aerobic fitness and the brain: increased N-acetyl-aspartate and choline concentrations in endurance-trained middle-aged adults.
  Gonzales MM, Tarumi T, Kaur S, Nualnim N, Fallow BA, Pyron M, Tanaka H, Haley AP. Gonzales MM, et al. Brain Topogr. 2013 Jan;26(1):126-34. doi: 10.1007/s10548-012-0248-8. Epub 2012 Aug 28. Brain Topogr. 2013. PMID: 22926147 Free PMC article.
• Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
  Liu Y, Cai ZL, Xue S, Zhou X, Wu F. Liu Y, et al. J Clin Neurosci. 2013 Apr;20(4):548-53. doi: 10.1016/j.jocn.2012.04.020. Epub 2013 Feb 11. J Clin Neurosci. 2013. PMID: 23406880
• Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
  Yildiz-Yesiloglu A, Ankerst DP. Yildiz-Yesiloglu A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. doi: 10.1016/j.pnpbp.2006.03.012. Epub 2006 May 4. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16677749 Review.
• Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
  Tumati S, Martens S, Aleman A. Tumati S, et al. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2571-86. doi: 10.1016/j.neubiorev.2013.08.004. Epub 2013 Aug 19. Neurosci Biobehav Rev. 2013. PMID: 23969177 Review.

Cited by

• Posttraumatic stress disorder: A metabolic disorder in disguise?
  Michopoulos V, Vester A, Neigh G. Michopoulos V, et al. Exp Neurol. 2016 Oct;284(Pt B):220-229. doi: 10.1016/j.expneurol.2016.05.038. Epub 2016 May 28. Exp Neurol. 2016. PMID: 27246996 Free PMC article. Review.
• Change in medial frontal cerebral metabolite concentrations following bariatric surgery.
  Bottari SA, Cohen RA, Friedman J, Porges EC, Chen A, Britton MK, Gunstad J, Woods AJ, Williamson JB. Bottari SA, et al. NMR Biomed. 2023 Jul;36(7):e4897. doi: 10.1002/nbm.4897. Epub 2023 Feb 11. NMR Biomed. 2023. PMID: 36628927 Free PMC article.
• Validation of a single factor representing the indicators of metabolic syndrome as a continuous measure of metabolic load and its association with health and cognitive function.
  Düzel S, Buchmann N, Drewelies J, Gerstorf D, Lindenberger U, Steinhagen-Thiessen E, Norman K, Demuth I. Düzel S, et al. PLoS One. 2018 Dec 12;13(12):e0208231. doi: 10.1371/journal.pone.0208231. eCollection 2018. PLoS One. 2018. PMID: 30540802 Free PMC article.
• Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
  Vigneswaran S, Rojas JH, Garvey L, Taylor-Robinson S, Winston A. Vigneswaran S, et al. Neuroradiol J. 2015 Dec;28(6):545-54. doi: 10.1177/1971400915609867. Epub 2015 Oct 22. Neuroradiol J. 2015. PMID: 26493269 Free PMC article.
• Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome.
  Haley AP, Gonzales MM, Tarumi T, Tanaka H. Haley AP, et al. Metab Brain Dis. 2012 Dec;27(4):513-20. doi: 10.1007/s11011-012-9306-x. Epub 2012 May 3. Metab Brain Dis. 2012. PMID: 22552897 Free PMC article.

References

1. 1. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
2. 1. Magn Reson Med. 1994 Jul;32(1):110-5 - PubMed
3. 1. Biophys Chem. 1997 Oct;68(1-3):161-72 - PubMed
4. 1. Diabetes Care. 2010 Jan;33(1):84-9 - PubMed
5. 1. Diabetes Care. 2007 Oct;30(10):2655-60 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information